Searchable abstracts of presentations at key conferences in endocrinology

ea0044p66 | Clinical biochemistry | SFEBES2016

Audit of plasma catecholamines vs. plasma metanephrines: experience at a tertiary endocrine referral centre

Taylor David R , Alexander Alex , Schweitzer Adam , Stone Colin , Whitelaw Ben , Aylwin Simon , Vincent Royce P

Background: Phaeochromocytoma and paraganglioma (PPGLs) are rare neuroendocrine tumours arising from the adrenal medulla and paraganglia. Biochemical assessment relies on demonstrating elevated concentrations of catecholamines and their metabolites. Analytical methods for catecholamine and metanephrine measurement vary in sensitivity and specificity. We reviewed our biochemical work-up in order to optimise patient diagnosis.Methods: This retrospective au...

ea0044p239 | Thyroid | SFEBES2016

Optimising the medical treatment of Graves’ Disease through developing a novel carbimazole dosing-algorithm

Brewster Rosalind , Abbara Ali , Clarke Sophie , Comninos Alexander , Peters Deborah , Sam Amir , Meeran Karim , Dhillo Waljit

Introduction: Graves’ disease is the commonest cause of hyperthyroidism accounting for 80% of all cases. The first line treatment for Graves’ disease in the UK is medical therapy, most frequently using a ‘dose-titration’ regimen. Currently, there is a lack of guidance to aid clinicians in carrying out optimal dose-titration of carbimazole, resulting in a risk of under- or over-treatment. Thus, we aimed to develop a carbimazole dosing-algorithm for the medic...

ea0041oc4.5 | Thyroid - Clinical | ECE2016

Risk factors of relapse in Graves’ disease? Results from a systematic review and meta-analysis

Struja Tristan , Fehlberg Hannah , Kutz Alexander , Gubelin Larissa , Degen Christian , Muller Beat , Schutz Philipp

Context: Identification of risk factors predicting relapse in patients with hyperthyroidism of Graves’ disease after the first cycle with standard thyreostatic therapy [ATD] is important to guide therapeutic options.Objective: We performed a systematic review and meta-analysis to study predictors for risk of relapse after the first treatment episode with ATD in patients with Graves’ disease induced hyperthyroidism.Data so...

ea0041gp168 | Pituitary - Clinical (1) | ECE2016

Dynamics of adrenocorticotropin after stimulation with metyrapone (DYNAMO)

Noe Sebastian , von Werder Alexander , Iakoubov Roman , Neu Bruno , Schneider Heike , Thaler Markus , Luppa Peter

Purpose: To investigate the kinetics of adrenocorticotropin (ACTH) following oral metyrapone administration and describe differences between ACTH-deficient and non ACTH-deficient subjects.Methods: Patients from a tertiary endocrine center at a University Hospital in Munich, Germany, were tested. Metyrapone (Metopirone, HRA Pharma, France) was administered with a dosage of 40 mg/kg bodyweight at 0800 h. Consecutive levels of ACTH were determined at 0, 60,...

ea0041ep13 | Adrenal cortex (to include Cushing's) | ECE2016

Immunohistochemical characteristics of blood vessels in non-visualized and visualized on MRI pituitary adenomas in patients with Cushing’s disease (pilot study)

Voronkova Iya , Belaya Zhanna , Khandaeva Patimat , Rozhinskaya Liudmila , Vorontsov Alexander , Sitkin Ivan , Grigoriev Andrey , Melnichenko Galina

Introduction: Regardless of improvements in MRI, up to 20% of ACTH-secreting pituitary tumors are only identified at surgical exploration. The objective was to estimate whether there is any difference in blood vessels and the subsequent ability to uptake contrast agent in visualized micro-adenomas as compared to non-visualized on MRI ACTH-secreting pituitary tumors.Materials and methods: Retrospective evaluation of ACTH-positive pituitary tumors from pat...

ea0041ep451 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Gut microbiota and diet in patients with various glucose tolerance

Egshatyan Lilit , Kashtanova Daria , Popenko Anna , Tkacheva Olga , Tyakht Alexander , Alexeev Dmitry , Karamnova Natalia , Boytsov Sergey

Background: Type 2 diabetes (T2D) is a progressive disease. The gut microbiota has recently been identified as a new potential diabetes risk factor.Design: To investigate the gut microbiota composition in association with the dietary patterns in patients with different glucose tolerance we analyzed 92 patients: with normal glucose tolerance (n=48), prediabetes (n=24) and T2D (n=20). Metagenomic analysis was performed using 16Sr...

ea0041ep573 | Diabetes therapy | ECE2016

The influence of α-lipoic acid to endothelial dysfunction and adipokines balance in patients with type 2 diabetes and essential hypertension in the presence of unfavorable genetic polymorphism

Shalimova Anna , Belovol Alexander , Bobronnikova Lesya , Kochueva Marina , Psareva Valentina , Kirichenko Natalya

The aim: To establish unfavorable genetic polymorphisms on the development of comorbidity of DM2 and EH in Ukrainian population and to evaluate the effectiveness of α-lipoic acid appointment (α-LC) in complex therapy in patients with 3-4 crossed unfavorable genetic polymorphisms.The primary examination of 167 patients with DM2 in combination with EH showed that A/C and C/C genotypes of AGTR1, Pro/Pro genotype of PPARγ2, Arg/Arg ...

ea0041ep934 | Pituitary - Clinical | ECE2016

The outcomes of the transsphenoidal adenomectomy in patients with acromegaly

Tsiberkin Alexander , Cherebillo Vladislav , Tsoi Ulyana , Dalmatova Anna , Belousova Lydia , Grineva Elena

Introduction: Acromegaly is a chronic disorder caused by growth hormone (GH) hyperproduction which leads to significant morbidity and mortality primarily due to cardiovascular and respiratory complications. Pituitary adenoma is the main cause of GH’s hyperproduction. By current guidelines transsphenoidal surgery (TSS) is the first-line treatment in acromegaly patients.Aim: To evaluate the results of TSS in acromegaly patients 6 months after surgery....

ea0041ep1003 | Thyroid (non-cancer) | ECE2016

Does Immunosuppressive Therapy improve outcomes in Graves’ disease: Results from a Systematic Review and Meta-analysis

Struja Tristan , Gubelin Larissa , Kutz Alexander , Fehlberg Hannah , Muller Beat , Schutz Philipp

Objective: Whether additional immunosuppressive drugs to standard treatment with thyreostatic drugs reduce the risk for relapse in Graves’ disease is not well understood. We performed a systematic review and meta-analysis to study the effects of immunosuppressive drugs on relapse rate and treatment effect of patients with hyperthyroidism due to Graves’ disease.Methods: We searched PubMed, EMBASE and Cochrane in July 2015 for randomized-controll...

ea0041ep1039 | Thyroid (non-cancer) | ECE2016

Comparison of thyroid nodule prevalence in two population-based studies in Bulgaria: 2006 and 2012

Shinkov Alexander , Borissova Anna-Maria , Kovatcheva Roussanka , Dakovska Lilia , Vlahov Jordan , Vukov Mirtcho

The nodular goiter is the most prevalent thyroid disorder. Its prevalence increases with age and reaches over 70%. The aim of the study was to compare the nodule prevalence in two population-based studies, carried in Bulgaria in 2006 and 2012.Material and methods: Two thousand four hundred and two subjects (1347 female and 1053 male, age range 20–94 years) were included in 2006 and 2022 (1073 female and 949 male, 20–88 years) in 2012. All subje...